|Product Name||Cat. No.||Compounds||Size (10 mM in Pre-dissolved in DMSO )|
|Anti-Cancer Active Compounds
|LA-006||Active Compounds 159
M Series 296
C Series 371
10 μL/well, 20 μL/well, or 100 μL/well
In currently, Cancer one of the most common and most serious diseases that directly endanger human life. According to incomplete statistics, nearly 20 million people in the world suffer from cancer every year, and about 10 million people die from cancer, accounting for the total number of deaths. About 1/4, this number is still growing rapidly.
Cancer is a chronic disease that the world medical community has been unable to overcome for a long time. One of the reasons is that the modern medical community has not really understood the cause of cancer. To this end, the library contains 159 anti-cancer active molecules, and the M+C series are transformed into potential new active molecules on each parent (~660), which can be widely used in high-throughput screening (HTS). ) And high-content screening (HCS), providing important clues for optimizing drug structure; at the same time, we continue to provide customized P-series molecules (~117 modified), which can be used for precise protein profiling research and discovery of drugs in various cells , Including the binding of human living cells to various protein targets, for in-depth research on the mechanism of drug action and drug modification.